載入...
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
OBJECTIVES: To develop and validate a genetic tool to predict age of onset of aggressive prostate cancer (PCa) and to guide decisions of who to screen and at what age. DESIGN: Analysis of genotype, PCa status, and age to select single nucleotide polymorphisms (SNPs) associated with diagnosis. These...
Na minha lista:
| 發表在: | BMJ |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group Ltd.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5759091/ https://ncbi.nlm.nih.gov/pubmed/29321194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.j5757 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|